Proven percutaneous AV fistula technology set to re-enter the market with phased rollout in 2026 ...

Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat ...

Aspirin is considered the cornerstone of secondary prevention of coronary artery disease. However, the evidence supporting aspirin was largely generated before the advent of modern pharmacological and ...

France: A recent meta-analysis published in Radiology has reaffirmed the strong safety profile of percutaneous thermal ...

Complex percutaneous coronary intervention (PCI) in patients with severely impaired left ventricular function carries a high risk of death and complications. Whether percutaneous left ventricular ...

Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable ...

Percutaneous coronary intervention (PCI) is increasingly used for revascularization of unprotected left main coronary artery disease. Whether intravascular ultrasonographic (IVUS) guidance during ...

Percutaneous transluminal angioplasty (PCTA) is a surgical procedure to treat heart disease. It involves inserting a small balloon into the arteries to manage blockages or restore blood flow. A person ...

Interventional cardiology made its debut 27 years ago, when Andreas Grüntzig performed the first percutaneous transluminal coronary angioplasty in a human. Since then, rapid expansion of our knowledge ...

Ellipsys Medical, Inc. announced that the Ellipsys vascular access system will re-enter the market, with commercial availabil ...